| Related Articles |
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus.
Diabet Med. 2018 May 23;:
Authors: Li YG, Pastori D, Lip GYH
Abstract
Atrial fibrillation (AF) is associated with various cardiovascular comorbidities, such as hypertension, heart failure and diabetes mellitus, which increases not only the risk of ischaemic stroke but also of myocardial infarction and mortality. Oral anticoagulation for stroke prevention is the cornerstone of management for people with AF, both with vitamin K antagonists, or with non-vitamin K antagonist oral anticoagulants (NOACs), which show efficacy, safety and convenience compared with vitamin K antagonists [1]. This article is protected by copyright. All rights reserved.
PMID: 29790596 [PubMed - as supplied by publisher]